BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 36414916)

  • 1. RGS16 regulated by let-7c-5p promotes glioma progression by activating PI3K-AKT pathway.
    Wang C; Xue H; Zhao R; Sun Z; Gao X; Qi Y; Wang H; Xu J; Deng L; Li G
    Front Med; 2023 Feb; 17(1):143-155. PubMed ID: 36414916
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Delivery of MicroRNA-let-7c-5p by Biodegradable Silica Nanoparticles Suppresses Human Cervical Carcinoma Cell Proliferation and Migration.
    Shao L; Wang R; Sun Y; Yue Z; Sun H; Wang X; Wang P; Sun G; Hu J; Sun H; Xie S; Li Y
    J Biomed Nanotechnol; 2020 Nov; 16(11):1600-1611. PubMed ID: 33461652
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The miR-139-5p regulates proliferation of supratentorial paediatric low-grade gliomas by targeting the PI3K/AKT/mTORC1 signalling.
    Catanzaro G; Besharat ZM; Miele E; Chiacchiarini M; Po A; Carai A; Marras CE; Antonelli M; Badiali M; Raso A; Mascelli S; Schrimpf D; Stichel D; Tartaglia M; Capper D; von Deimling A; Giangaspero F; Mastronuzzi A; Locatelli F; Ferretti E
    Neuropathol Appl Neurobiol; 2018 Dec; 44(7):687-706. PubMed ID: 29478280
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [miR-let-7c-5p inhibits invasion and migration of bladder cancer cells by targeting HMGA2].
    Yao Y; Zhang C; Xiong Y; Han B; Gao X; Wang S
    Nan Fang Yi Ke Da Xue Xue Bao; 2021 Jul; 41(7):1022-1029. PubMed ID: 34308851
    [TBL] [Abstract][Full Text] [Related]  

  • 5. miR-489 inhibits proliferation, cell cycle progression and induces apoptosis of glioma cells via targeting SPIN1-mediated PI3K/AKT pathway.
    Li Y; Ma X; Wang Y; Li G
    Biomed Pharmacother; 2017 Sep; 93():435-443. PubMed ID: 28666210
    [TBL] [Abstract][Full Text] [Related]  

  • 6.
    Zheng Y; Luo M; Lü M; Zhou T; Liu F; Guo X; Zhang J; Kang M
    Onco Targets Ther; 2020; 13():11193-11209. PubMed ID: 33173311
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anwuligan inhibits the progression of non-small cell lung cancer via let-7c-3p/PI3K/AKT/mTOR axis.
    Niu H; Wang D; Wen T; Liu H; Jie J; Song L; Li D
    Cancer Med; 2023 Mar; 12(5):5908-5925. PubMed ID: 36412203
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LncRNA BCYRN1 inhibits glioma tumorigenesis by competitively binding with miR-619-5p to regulate CUEDC2 expression and the PTEN/AKT/p21 pathway.
    Mu M; Niu W; Zhang X; Hu S; Niu C
    Oncogene; 2020 Nov; 39(45):6879-6892. PubMed ID: 32978519
    [TBL] [Abstract][Full Text] [Related]  

  • 9. GNG12 Targeted by miR-876-5p Contributes to Glioma Progression Through the Activation of the PI3K/AKT Signaling Pathway.
    Li L; Zhang Q; Yuan L; Yang Y; Wang X; Liu F; Liu Y; Xie M
    J Mol Neurosci; 2022 Feb; 72(2):441-450. PubMed ID: 35083664
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytological effects of honokiol treatment and its potential mechanism of action in non-small cell lung cancer.
    Zhang J; Zhang Y; Shen W; Fu R; Ding Z; Zhen Y; Wan Y
    Biomed Pharmacother; 2019 Sep; 117():109058. PubMed ID: 31176168
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA let-7c-5p Suppressed Lipopolysaccharide-Induced Dental Pulp Inflammation by Inhibiting Dentin Matrix Protein-1-Mediated Nuclear Factor kappa B (NF-κB) Pathway In Vitro and In Vivo.
    Yuan H; Zhang H; Hong L; Zhao H; Wang J; Li H; Che H; Zhang Z
    Med Sci Monit; 2018 Sep; 24():6656-6665. PubMed ID: 30238933
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MiR-199a-5p and let-7c cooperatively inhibit migration and invasion by targeting MAP4K3 in hepatocellular carcinoma.
    Liu L; Lu L; Zheng A; Xie J; Xue Q; Wang F; Wang X; Zhou H; Tong X; Li Y; Zhu X; Wu G
    Oncotarget; 2017 Feb; 8(8):13666-13677. PubMed ID: 28099144
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA-425-5p promotes breast cancer cell growth by inducing PI3K/AKT signaling.
    Zhang LF; Zhang JG; Zhou H; Dai TT; Guo FB; Xu SY; Chen Y
    Kaohsiung J Med Sci; 2020 Apr; 36(4):250-256. PubMed ID: 31688991
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long non-coding RNA LPP-AS2 promotes glioma tumorigenesis via miR-7-5p/EGFR/PI3K/AKT/c-MYC feedback loop.
    Zhang X; Niu W; Mu M; Hu S; Niu C
    J Exp Clin Cancer Res; 2020 Sep; 39(1):196. PubMed ID: 32962742
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MiR-30c-5p loss-induced PELI1 accumulation regulates cell proliferation and migration via activating PI3K/AKT pathway in papillary thyroid carcinoma.
    Zheng T; Zhou Y; Xu X; Qi X; Liu J; Pu Y; Zhang S; Gao X; Luo X; Li M; Wang X; Dong L; Wang Y; Mao C
    J Transl Med; 2022 Jan; 20(1):20. PubMed ID: 34991623
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA let-7c is downregulated in prostate cancer and suppresses prostate cancer growth.
    Nadiminty N; Tummala R; Lou W; Zhu Y; Shi XB; Zou JX; Chen H; Zhang J; Chen X; Luo J; deVere White RW; Kung HJ; Evans CP; Gao AC
    PLoS One; 2012; 7(3):e32832. PubMed ID: 22479342
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Let-7c Inhibits the Proliferation, Invasion, and Migration of Glioma Cells via Targeting E2F5.
    Huang M; Gong X
    Oncol Res; 2018 Aug; 26(7):1103-1111. PubMed ID: 29362021
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypoxic glioma-derived extracellular vesicles harboring MicroRNA-10b-5p enhance M2 polarization of macrophages to promote the development of glioma.
    Li B; Yang C; Zhu Z; Chen H; Qi B
    CNS Neurosci Ther; 2022 Nov; 28(11):1733-1747. PubMed ID: 36052751
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MiR-155-5p exerts tumor-suppressing functions in Wilms tumor by targeting IGF2 via the PI3K signaling pathway.
    Luo X; Dong J; He X; Shen L; Long C; Liu F; Liu X; Lin T; He D; Wei G
    Biomed Pharmacother; 2020 May; 125():109880. PubMed ID: 32004974
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exosomes of A549 Cells Induced Migration, Invasion, and EMT of BEAS-2B Cells Related to let-7c-5p and miR-181b-5p.
    Liu Y; Su CY; Yan YY; Wang J; Li JJ; Fu JJ; Wang YQ; Zhang JY
    Front Endocrinol (Lausanne); 2022; 13():926769. PubMed ID: 35898472
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.